CD47 antibody helps phagocytes fight paediatric cancer

被引：0
|
作者：
Charlotte Ridler
机构：
来源：
Nature Reviews Neurology | 2017年 / 13卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：258 / 258
相关论文
共 50 条
  • [31] CD47: the next checkpoint target for cancer immunotherapy
    Feng, Ridong
    Zhao, Hai
    Xu, Jianguo
    Shen, Chongyang
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2020, 152
  • [32] CD47 receptor as a primary target for cancer therapy
    N. M. Ratnikova
    Y. N. Lezhnin
    E. I. Frolova
    J. E. Kravchenko
    S. P. Chumakov
    Molecular Biology, 2017, 51 : 216 - 225
  • [33] Targeting CD47 as a Novel Immunotherapy for Breast Cancer
    Chen, Can
    Wang, Runlu
    Chen, Xi
    Hou, Yulong
    Jiang, Jingting
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [34] CD47 blockade enhances the efficacy of intratumoral STING-targeting therapy by activating phagocytes
    Kosaka, Akemi
    Ishibashi, Kei
    Nagato, Toshihiro
    Kitamura, Hidemitsu
    Fujiwara, Yukio
    Yasuda, Syunsuke
    Nagata, Marino
    Harabuchi, Shohei
    Hayashi, Ryusuke
    Yajima, Yuki
    Ohara, Kenzo
    Kumai, Takumi
    Aoki, Naoko
    Komohara, Yoshihiro
    Oikawa, Kensuke
    Harabuchi, Yasuaki
    Kitada, Masahiro
    Kobayashi, Hiroya
    Ohkuri, Takayuki
    JOURNAL OF EXPERIMENTAL MEDICINE, 2021, 218 (11):
  • [35] CD47 is highly expressed in gliomas and targeting CD47 is a promising therapeutic strategy
    Yang, Jiaying
    Yao, Yongjun
    Tong, Li
    Zhu, Ziwei
    Wang, Lei
    Yang, Jinju
    EUROPEAN JOURNAL OF INFLAMMATION, 2021, 19
  • [36] Dual-targeting mesothelin/CD47 bispecific antibodies for tumor-directed blockade of CD47 in solid cancer
    Moine, Valery
    Broyer, Lucile
    Chauchet, Xavier
    Hatterer, Eric
    Majocchi, Stefano
    Buatois, Vanessa
    Shang, Limin
    Didelot, Gerard
    Magistrelli, Giovanni
    Poitevin, Yves
    Ravn, Ulla
    Kosco-Vilbois, Marie H.
    Fiischer, Nicolas
    Ferlin, Walter G.
    Masternak, Krzysztof
    CANCER RESEARCH, 2018, 78 (13)
  • [37] Exploration of the Therapeutic Effects of CD47 and CD38 Antibody Combination in Relapsed or Refractory Multiple Myeloma (rrMM) and the Correlation with CD47 and CD38 Expression
    Zhang, Yanni
    Sheng, Zhen
    Xia, Jie
    Ye, Chunyan
    Liu, Yan
    Wang, Zhengyi
    Hayslip, John
    Zhu, Andrew
    BLOOD, 2022, 140 : 9937 - 9938
  • [38] Preclinical development of a bispecific antibody-trap selectively targeting CD47 and CD24 for cancer immunotherapy
    Tian, Wenzhi
    Li, Song
    Chen, Dianze
    Liu, Dandan
    Guo, Huiqin
    Yang, Chunmei
    Zhang, Li
    Zhang, Wei
    Tu, Xiaoping
    Peng, Liang
    Zhao, Gui
    Zhang, Ruliang
    Zhang, Fan
    CANCER RESEARCH, 2022, 82 (12)
  • [39] CD47 on artificial structures
    Schuetz, Christian
    AGING-US, 2015, 7 (08): : 513 - 514
  • [40] An antibody–toxin conjugate targeting CD47 linked to the bacterial toxin listeriolysin O for cancer immunotherapy
    Benjamin R. Schrank
    Yifan Wang
    Annette Wu
    Nhat Tran
    DaeYong Lee
    Jared Edwards
    Kristin Huntoon
    Shiyan Dong
    JongHoon Ha
    Yifan Ma
    Adam J. Grippin
    Seong Dong Jeong
    Abin Antony
    Mengyu Chang
    Minjeong Kang
    Thomas D. Gallup
    Albert C. Koong
    Jing Li
    Kyuson Yun
    Betty Y. S. Kim
    Wen Jiang
    Nature Cancer, 2025, 6 (3) : 511 - 527
12345